Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACO: Weekly Versus Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer
NCT01561586Phase 3Unknown
- Sponsor
- Korea Cancer Center Hospital
- Start
- Mar 2012
- Primary completion
- Mar 2020
- Modality
- Nanoparticles, Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised trial of Cisplatin micelle injection (HA132) in Cervical Cancer (CC) (2 arms), sponsored by Korea Cancer Center Hospital. Primary endpoint: Overall Survival at 5 years. Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01561586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01561586.